Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Mylan_Inc.
|
| gptkbp:acquisitionYear |
2006
|
| gptkbp:country |
gptkb:India
|
| gptkbp:foundedIn |
1981
|
| gptkbp:founder |
gptkb:Nimmagadda_Prasad
|
| gptkbp:headquartersLocation |
gptkb:Hyderabad
|
| https://www.w3.org/2000/01/rdf-schema#label |
Matrix Laboratories
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:keyPerson |
gptkb:Nimmagadda_Prasad
|
| gptkbp:parentCompany |
gptkb:Mylan_Inc.
|
| gptkbp:products |
active pharmaceutical ingredients
finished dosage forms |
| gptkbp:stockExchange |
gptkb:Bombay_Stock_Exchange
gptkb:National_Stock_Exchange_of_India |
| gptkbp:bfsParent |
gptkb:Mylan
|
| gptkbp:bfsLayer |
7
|